A citation-based method for searching scientific literature

Mary Linton Peters, Judy E Garber, Nadine Tung. Gynecol Oncol 2017
Times Cited: 8







List of co-cited articles
21 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
994
37

Breast cancer following ovarian cancer in BRCA mutation carriers.
Alexandra Gangi, Ilana Cass, Daniel Paik, Galinos Barmparas, Beth Karlan, Catherine Dang, Andrew Li, Christine Walsh, Bobbie J Rimel, Farin F Amersi. JAMA Surg 2014
26
25

The risk of primary and contralateral breast cancer after ovarian cancer in BRCA1/BRCA2 mutation carriers: Implications for counseling.
Peggy M L H Vencken, Mieke Kriege, Maartje Hooning, Marian B Menke-Pluymers, Bernadette A M Heemskerk-Gerritsen, Lena C van Doorn, Margriet M Collée, Agnes Jager, Cees van Montfort, Curt W Burger,[...]. Cancer 2013
20
25

Risk of breast cancer after a diagnosis of ovarian cancer in BRCA mutation carriers: Is preventive mastectomy warranted?
Jacob McGee, Vasily Giannakeas, Beth Karlan, Jan Lubinski, Jacek Gronwald, Barry Rosen, John McLaughlin, Harvey Risch, Ping Sun, William D Foulkes,[...]. Gynecol Oncol 2017
21
25

Risk of second primary cancer among women with breast cancer: a population-based study in Granada (Spain).
Esther Molina-Montes, Marina Pollán, Tilman Payer, Elena Molina, Cristina Dávila-Arias, María-José Sánchez. Gynecol Oncol 2013
22
25

Risk of metachronous breast cancer after BRCA mutation-associated ovarian cancer.
Susan M Domchek, Komal Jhaveri, Sujata Patil, Jill E Stopfer, Clifford Hudis, Jacquelyn Powers, Zsofia Stadler, Laura Goldstein, Noah Kauff, Mustafa Khasraw,[...]. Cancer 2013
34
25

Risk of ovarian cancer in breast-cancer patients with a family history of breast or ovarian cancer: a population-based cohort study.
Kjell Bergfeldt, Bosse Rydh, Fredrik Granath, Henrik Grönberg, Lukman Thalib, Hans-Olov Adami, Per Hall. Lancet 2002
46
25

BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group.
Kathryn Alsop, Sian Fereday, Cliff Meldrum, Anna deFazio, Catherine Emmanuel, Joshy George, Alexander Dobrovic, Michael J Birrer, Penelope M Webb, Colin Stewart,[...]. J Clin Oncol 2012
724
25

Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors.
Jason I Herschkowitz, Karl Simin, Victor J Weigman, Igor Mikaelian, Jerry Usary, Zhiyuan Hu, Karen E Rasmussen, Laundette P Jones, Shahin Assefnia, Subhashini Chandrasekharan,[...]. Genome Biol 2007
813
25

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
T Sørlie, C M Perou, R Tibshirani, T Aas, S Geisler, H Johnsen, T Hastie, M B Eisen, M van de Rijn, S S Jeffrey,[...]. Proc Natl Acad Sci U S A 2001
25

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer.
Aleix Prat, Joel S Parker, Olga Karginova, Cheng Fan, Chad Livasy, Jason I Herschkowitz, Xiaping He, Charles M Perou. Breast Cancer Res 2010
25

Repeated observation of breast tumor subtypes in independent gene expression data sets.
Therese Sorlie, Robert Tibshirani, Joel Parker, Trevor Hastie, J S Marron, Andrew Nobel, Shibing Deng, Hilde Johnsen, Robert Pesich, Stephanie Geisler,[...]. Proc Natl Acad Sci U S A 2003
25


Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapies.
Jeffrey S Ross, Laurie M Gay, Kai Wang, Siraj M Ali, Saranya Chumsri, Julia A Elvin, Ron Bose, Jo-Anne Vergilio, James Suh, Roman Yelensky,[...]. Cancer 2016
47
25

Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers.
Karoline B Kuchenbaecker, Susan L Neuhausen, Mark Robson, Daniel Barrowdale, Lesley McGuffog, Anna Marie Mulligan, Irene L Andrulis, Amanda B Spurdle, Marjanka K Schmidt, Rita K Schmutzler,[...]. Breast Cancer Res 2014
46
25

Molecular portraits of human breast tumours.
C M Perou, T Sørlie, M B Eisen, M van de Rijn, S S Jeffrey, C A Rees, J R Pollack, D T Ross, H Johnsen, L A Akslen,[...]. Nature 2000
25

Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
Kathleen Moore, Nicoletta Colombo, Giovanni Scambia, Byoung-Gie Kim, Ana Oaknin, Michael Friedlander, Alla Lisyanskaya, Anne Floquet, Alexandra Leary, Gabe S Sonke,[...]. N Engl J Med 2018
978
25

Oncologic Safety of Prophylactic Nipple-Sparing Mastectomy in a Population With BRCA Mutations: A Multi-institutional Study.
James W Jakub, Anne Warren Peled, Richard J Gray, Rachel A Greenup, John V Kiluk, Virgilio Sacchini, Sarah A McLaughlin, Julia C Tchou, Robert A Vierkant, Amy C Degnim,[...]. JAMA Surg 2018
76
25


Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study.
Ellen R Copson, Tom C Maishman, Will J Tapper, Ramsey I Cutress, Stephanie Greville-Heygate, Douglas G Altman, Bryony Eccles, Sue Gerty, Lorraine T Durcan, Louise Jones,[...]. Lancet Oncol 2018
158
25

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
25

Engineering Vaccines to Reprogram Immunity against Head and Neck Cancer.
Y S Tan, K Sansanaphongpricha, M E P Prince, D Sun, G T Wolf, Y L Lei. J Dent Res 2018
18
12

Identification of the Cell-Intrinsic and -Extrinsic Pathways Downstream of EGFR and IFNγ That Induce PD-L1 Expression in Head and Neck Cancer.
Fernando Concha-Benavente, Raghvendra M Srivastava, Sumita Trivedi, Yu Lei, Uma Chandran, Raja R Seethala, Gordon J Freeman, Robert L Ferris. Cancer Res 2016
172
12

Gene expression profiling predicts the development of oral cancer.
Pierre Saintigny, Li Zhang, You-Hong Fan, Adel K El-Naggar, Vassiliki A Papadimitrakopoulou, Lei Feng, J Jack Lee, Edward S Kim, Waun Ki Hong, Li Mao. Cancer Prev Res (Phila) 2011
88
12

The role of epidermal growth factor receptor in head and neck squamous cell carcinoma.
Rebecca G Pomerantz, Jennifer Rubin Grandis. Curr Oncol Rep 2003
39
12

The PI3K/Akt/mTOR axis in head and neck cancer: functions, aberrations, cross-talk, and therapies.
R Vander Broek, S Mohan, D F Eytan, Z Chen, C Van Waes. Oral Dis 2015
96
12

Biomarkers of epithelial-mesenchymal transition in squamous cell carcinoma.
C S Scanlon, E A Van Tubergen, R C Inglehart, N J D'Silva. J Dent Res 2013
199
12

Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1-Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study.
Chiun Hsu, Se-Hoon Lee, Samuel Ejadi, Caroline Even, Roger B Cohen, Christophe Le Tourneau, Janice M Mehnert, Alain Algazi, Emilie M J van Brummelen, Sanatan Saraf,[...]. J Clin Oncol 2017
197
12

RAD51C--a new human cancer susceptibility gene for sporadic squamous cell carcinoma of the head and neck (HNSCC).
Kathrin Scheckenbach, Stephan E Baldus, Vera Balz, Marcel Freund, Petra Pakropa, Christoph Sproll, Karl-Ludwig Schäfer, Martin Wagenmann, Jörg Schipper, Helmut Hanenberg. Oral Oncol 2014
23
12

Therapeutic Efficacy of Cancer Stem Cell Vaccines in the Adjuvant Setting.
Yangyang Hu, Lin Lu, Yang Xia, Xin Chen, Alfred E Chang, Robert E Hollingsworth, Elaine Hurt, John Owen, Jeffrey S Moyer, Mark E P Prince,[...]. Cancer Res 2016
37
12

Genomics and advances towards precision medicine for head and neck squamous cell carcinoma.
Carter Van Waes, Omar Musbahi. Laryngoscope Investig Otolaryngol 2017
7
14

EGFR-targeted mAb therapy modulates autophagy in head and neck squamous cell carcinoma through NLRX1-TUFM protein complex.
Y Lei, B A Kansy, J Li, L Cong, Y Liu, S Trivedi, H Wen, J P-Y Ting, H Ouyang, R L Ferris. Oncogene 2016
38
12

Recurrent CDK1 overexpression in laryngeal squamous cell carcinoma.
K Bednarek, K Kiwerska, M Szaumkessel, M Bodnar, M Kostrzewska-Poczekaj, A Marszalek, J Janiszewska, A Bartochowska, J Jackowska, M Wierzbicka,[...]. Tumour Biol 2016
22
12

First FDA Approval Agnostic of Cancer Site - When a Biomarker Defines the Indication.
Steven Lemery, Patricia Keegan, Richard Pazdur. N Engl J Med 2017
310
12

Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas.
Mark W Lingen, Weihong Xiao, Alessandra Schmitt, Bo Jiang, Robert Pickard, Paul Kreinbrink, Bayardo Perez-Ordonez, Richard C Jordan, Maura L Gillison. Oral Oncol 2013
228
12

PD-L1 on host cells is essential for PD-L1 blockade-mediated tumor regression.
Haidong Tang, Yong Liang, Robert A Anders, Janis M Taube, Xiangyan Qiu, Aditi Mulgaonkar, Xin Liu, Susan M Harrington, Jingya Guo, Yangchun Xin,[...]. J Clin Invest 2018
247
12

Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
Kevin J Harrington, Robert L Ferris, George Blumenschein, A Dimitrios Colevas, Jérôme Fayette, Lisa Licitra, Stefan Kasper, Caroline Even, Everett E Vokes, Francis Worden,[...]. Lancet Oncol 2017
207
12

Burden of HPV-positive oropharynx cancers among ever and never smokers in the U.S. population.
Anil K Chaturvedi, Gypsyamber D'Souza, Maura L Gillison, Hormuzd A Katki. Oral Oncol 2016
55
12

MEK Inhibitor PD-0325901 Overcomes Resistance to PI3K/mTOR Inhibitor PF-5212384 and Potentiates Antitumor Effects in Human Head and Neck Squamous Cell Carcinoma.
Suresh Mohan, Robert Vander Broek, Sujay Shah, Danielle F Eytan, Matthew L Pierce, Sophie G Carlson, Jamie F Coupar, Jialing Zhang, Hui Cheng, Zhong Chen,[...]. Clin Cancer Res 2015
44
12

Moving towards personalised therapy in head and neck squamous cell carcinoma through analysis of next generation sequencing data.
M Giefing, M Wierzbicka, K Szyfter, J C Brenner, B J Braakhuis, R H Brakenhoff, C R Bradford, J A Sorensen, A Rinaldo, J P Rodrigo,[...]. Eur J Cancer 2016
23
12

Quantification of excision repair cross-complementing group 1 and survival in p16-negative squamous cell head and neck cancers.
Ranee Mehra, Fang Zhu, Dong-Hua Yang, Kathy Q Cai, Joellen Weaver, Mahendra K Singh, Anna S Nikonova, Erica A Golemis, Douglas B Flieder, Harry S Cooper,[...]. Clin Cancer Res 2013
21
12

Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial.
Tanguy Y Seiwert, Barbara Burtness, Ranee Mehra, Jared Weiss, Raanan Berger, Joseph Paul Eder, Karl Heath, Terrill McClanahan, Jared Lunceford, Christine Gause,[...]. Lancet Oncol 2016
938
12


Head and neck squamous cell carcinoma in FAMMM syndrome.
Vladimir Vinarsky, Robert L Fine, Adel Assaad, Ying Qian, John A Chabot, Gloria H Su, Harold Frucht. Head Neck 2009
21
12

Phase II study of sunitinib in recurrent or metastatic squamous cell carcinoma of the head and neck: GORTEC 2006-01.
Jean-Pascal H Machiels, Stéphanie Henry, Sylvie Zanetta, Marie-Christine Kaminsky, Nicolas Michoux, Denis Rommel, Sandra Schmitz, Emmanuelle Bompas, Anne-Françoise Dillies, Sandrine Faivre,[...]. J Clin Oncol 2010
120
12

Genomic correlates of response to CTLA-4 blockade in metastatic melanoma.
Eliezer M Van Allen, Diana Miao, Bastian Schilling, Sachet A Shukla, Christian Blank, Lisa Zimmer, Antje Sucker, Uwe Hillen, Marnix H Geukes Foppen, Simone M Goldinger,[...]. Science 2015
12

Selecting Patients with Ovarian Cancer for Germline BRCA Mutation Testing: Findings from Guidelines and a Systematic Literature Review.
Diana M Eccles, Judith Balmaña, Joe Clune, Birgit Ehlken, Annegret Gohlke, Ceri Hirst, Danielle Potter, Claudia Schroeder, Jerzy E Tyczynski, Encarnacion B Gomez Garcia. Adv Ther 2016
33
12

Cetuximab-activated natural killer and dendritic cells collaborate to trigger tumor antigen-specific T-cell immunity in head and neck cancer patients.
Raghvendra M Srivastava, Steve C Lee, Pedro A Andrade Filho, Christopher A Lord, Hyun-Bae Jie, H Carter Davidson, Andrés López-Albaitero, Sandra P Gibson, William E Gooding, Soldano Ferrone,[...]. Clin Cancer Res 2013
203
12

The mutational landscape of head and neck squamous cell carcinoma.
Nicolas Stransky, Ann Marie Egloff, Aaron D Tward, Aleksandar D Kostic, Kristian Cibulskis, Andrey Sivachenko, Gregory V Kryukov, Michael S Lawrence, Carrie Sougnez, Aaron McKenna,[...]. Science 2011
12

Performance of common genetic variants in breast-cancer risk models.
Sholom Wacholder, Patricia Hartge, Ross Prentice, Montserrat Garcia-Closas, Heather Spencer Feigelson, W Ryan Diver, Michael J Thun, David G Cox, Susan E Hankinson, Peter Kraft,[...]. N Engl J Med 2010
323
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.